Fig. 1
From: Role of bile acids in the prediction of hepatocellular carcinoma in HCV-induced liver cirrhosis
Receiver operating characteristic curves for the 14 bile acids in the NHC, NCLD, and HCC: the corresponding analytical data obtained from ROC curve analysis including AUC, the cutoff point at the Youden’s index, the sensitivity, and the specificity of each bile acid are summarized in Table 3. NHC, normal healthy control; NCLD, noncirrhotic liver disease; CLD, cirrhotic liver diseases; HCC, hepatocellular carcinoma; TUDCA, tauroursodeoxycholic acid; TCA, taurocholic acid; GCA, glycholic acid; GUDCA, glycoursodeoxycholic acid; TCDCA, taurochenodeoxycholic acid; TDCA, taurodeoxycholic acid; CA, cholic acid; GCDCA, glycochenodeoxycholic acid; UDCA, ursodeoxycholic acid; GDCA, glycodeoxycholic acid; TLCA, taurolithocholic acid; CDCA, chenodeoxycholic acid; DCA, deoxycholic acid; LCA, lithocholic acid